Breast cancer is a malignant tumor that starts from cells of the
breast. A malignant
tumor
is a group of cancer cells that may invade surrounding tissues or
spread (metastasize) to distant areas of the body. The disease occurs
almost entirely in women, but men can get it, too. The remainder of
this document refers only to breast cancer in women. For information on
breast cancer in men, see the American Cancer Society's
document, Breast Cancer
in Men.
Normal Breast Structure
In order to understand breast cancer, it is helpful to have some basic
knowledge about the normal structure of the breasts.
The female breast is made up mainly of lobules
(milk-producing glands), ducts
(tiny tubes that carry the milk from the lobules to the nipple), and stroma (fatty
tissue
and connective tissue surrounding the ducts and lobules, blood vessels,
and lymphatic vessels).
Most breast cancers begin in the cells that line the ducts (ductal cancers);
some begin in the cells that line the lobules (lobular cancers),
and the rest in other tissues.
The Lymph (Lymphatic) System
The lymph system is important to understand because it is one
of the ways in which breast cancers can spread. This system has several
parts.
Lymph nodes
are small, bean-shaped collections of immune
system cells that are connected by lymphatic vessels. Lymphatic vessels
are like small veins, except that they carry a clear fluid called lymph
(instead of blood) away from the breast. Lymph contains
tissue fluid
and waste products, as well as immune system cells (cells that are
important in fighting infections). Breast cancer cells can enter
lymphatic vessels and begin to grow in lymph nodes.
Most lymphatic vessels in the breast connect to lymph nodes
under the arm (axillary
nodes). Some lymphatic vessels connect to lymph
nodes inside the chest (internal
mammary nodes) and those either above
or below the collarbone (supraclavicular
or infraclavicular
nodes).
Knowing if the cancer cells have spread to lymph nodes is
important because if it has, there is a higher chance that the cells
could have also gotten into the bloodstream and spread (metastasized)
to other sites in the body. The more lymph nodes that are involved with
the breast cancer, the more likely it is that the cancer may be found
in other organs as well. This is important to know because it could
affect your treatment plan. But not all women with lymph node
involvement develop metastases, and it is not unusual for a woman to
have negative lymph nodes and later develop metastases.
Benign Breast Lumps
Most breast lumps are not cancerous; that is, they are benign.
Still, some need to be sampled and viewed under a microscope to prove
they are not cancer.
Fibrocystic Changes
Most lumps turn out to be fibrocystic changes. The term
"fibrocystic" refers to fibrosis and cysts. Fibrosis is the formation
of fibrous (or scar-like) tissue, and cysts are fluid-filled sacs.
Fibrocystic changes can cause breast swelling and pain. This often
happens just before a period is about to begin. Your breasts may feel
lumpy and, sometimes, you may notice a clear or slightly cloudy nipple
discharge.
Other Benign Breast Lumps
Benign breast tumors such as fibroadenomas or intraductal
papillomas are abnormal growths, but they are not cancer
and cannot
spread outside of the breast to other organs. They are not life
threatening. Still, some benign breast conditions are important because
women with these conditions have a higher risk of developing breast
cancer.
For more information see the section, "What
Are the Risk Factors for Breast Cancer?" and the American
Cancer Society document, Noncancerous
Breast Conditions.
Breast Cancer General Terms
It is important to understand some of the key words used to
describe breast cancer.
Carcinoma
This is a term used to describe a cancer that begins in the
lining layer (epithelial cells) of organs such as the breast. Nearly
all breast cancers are carcinomas (either ductal carcinomas or lobular
carcinomas).
Adenocarcinoma
An adenocarcinoma is a type of carcinoma that starts in
glandular tissue (tissue that makes and secretes a substance). The
ducts and lobules of the breast are glandular tissue (they make breast
milk), so cancers starting in these areas are sometimes called
adenocarcinomas.
Carcinoma In Situ
This term is used for the early stage of cancer, when it is
confined to the layer of cells where it began. Specifically in breast
cancer, in situ
means that the cancer cells remain confined to ducts
(ductal carcinoma in situ) or lobules (lobular carcinoma in situ). They
have not invaded into deeper tissues in the breast or spread to other
organs in the body, and are sometimes referred to as non-invasive
breast cancers.
Invasive (Infiltrating) Carcinoma
An invasive cancer is one that has already invaded beyond the
layer of cells where it started (as opposed to carcinoma in situ). Most
breast cancers are invasive carcinomas -- either invasive ductal
carcinoma or invasive lobular carcinoma.
Sarcoma
Sarcomas are cancers that start from connective tissues such
as fat tissue or blood vessels. Sarcomas of the breast are rare.
Types of Breast Cancers
There are several types of breast cancer, although some of
them are quite rare. It is not unusual for a single breast tumor to be
a combination of these types and to have a mixture of invasive and in
situ cancer.
Ductal Carcinoma In Situ (DCIS)
Ductal carcinoma
in situ (also known as intraductal carcinoma)
is the most common type of non-invasive breast cancer. DCIS means that
the cancer cells are inside the ducts but have not spread through the
walls of the ducts into the surrounding breast tissue.
About 1 out of 5 new breast cancer cases will be DCIS. Nearly
all women diagnosed at this early stage of breast cancer can be cured.
A mammogram is often the best way to find DCIS early.
When DCIS is diagnosed, the pathologist (a doctor specializing
in diagnosing disease from tissue samples) will look for an area of
dead or dying cancer cells, called
tumor necrosis, within the tissue
sample. If necrosis is present, the tumor is likely to be more
aggressive. The term comedocarcinoma
is often used to describe DCIS
with necrosis.
Lobular Carcinoma In Situ (LCIS)
Although not a true cancer, LCIS (also called lobular
neoplasia) is sometimes classified as a type of
non-invasive breast
cancer, and this is why it is included here. It begins in the
milk-producing glands but does not grow through the wall of the
lobules.
Most breast cancer specialists think that LCIS itself does not
become an invasive cancer very often, but women with this condition do
have a higher risk of developing an invasive breast cancer in the same
breast or in the opposite breast. For this reason, women with LCIS
should pay close attention to having regular mammograms.
Invasive (or Infiltrating)
Ductal Carcinoma (IDC)
This is the most common type of breast cancer. It starts in a
milk passage (duct) of the breast, has broken through the wall of the
duct, and invaded the fatty tissue of the breast. At this point, it may
have the ability to spread (metastasize) to other parts of the body
through the lymphatic system and bloodstream. About 8 out of 10
invasive breast cancers are infiltrating ductal carcinomas.
Invasive (or Infiltrating)
Lobular Carcinoma (ILC)
Invasive lobular carcinoma starts in the milk-producing glands
(lobules). Like IDC, it can spread (metastasize) to other parts of the
body. About 1 out of 10 invasive breast cancers are ILCs. Invasive
lobular carcinoma may be harder to detect by a mammogram than invasive
ductal carcinoma.
Less Common Types of Breast
Cancer
Inflammatory
breast cancer: This uncommon type of invasive
breast cancer accounts for about 1% to 3% of all breast cancers.
Usually there is no single lump or tumor. Instead, inflammatory breast
cancer (IBC) makes the skin of the breast look red and feel warm and
gives the skin a thick, pitted appearance that looks a lot like an
orange peel. Doctors now know that these changes are not caused by
inflammation or infection, but by cancer cells blocking lymph vessels
in the skin. The affected breast may become larger or firmer, tender,
or itchy. Inflammatory breast cancer is often mistaken for infection
(mastitis) in its early stages. Because there is no defined lump, it
may not appear on a mammogram, which may make it even harder to catch
it early. It typically has a higher chance of spreading and a worse
outlook than typical invasive ductal or lobular cancer.
Mixed tumors: Mixed
tumors are those that contain a variety of
cell types, such as invasive ductal cancer combined with invasive
lobular breast cancer. In this situation, the tumor is treated as if it
were an invasive ductal cancer.
Medullary
cancer: This special type of infiltrating breast
cancer has a rather well-defined, distinct boundary between tumor
tissue and normal tissue. It also has some other special features,
including the large size of the cancer cells and the presence of immune
system cells at the edges of the tumor. Medullary carcinoma accounts
for about 3% to 5% of breast cancers. The outlook (prognosis) for this
kind of breast cancer is generally better than for the more common
types of invasive breast cancer. These are often hard to distinguish
from invasive ductal carcinoma. Most cancer specialists think that true
medullary cancer is very rare, and that cancers that are called
medullary cancer should be treated as the usual invasive ductal breast
cancer.
Metaplastic
carcinoma: Metaplastic carcinoma (also known as
carcinoma with metaplasia) is a very rare variant of invasive ductal
cancer. These tumors include cells that are normally not found in the
breast, such as cells that look like skin cells (squamous cells) or
cells that make bone. These tumors are treated like invasive ductal
cancer.
Mucinous
carcinoma: Also known as colloid carcinoma, this rare
type of invasive breast cancer is formed by mucus-producing cancer
cells. The prognosis for mucinous carcinoma is usually better than for
the more common types of invasive breast cancer.
Paget disease of
the nipple: This type of breast cancer starts
in the breast ducts and spreads to the skin of the nipple and then to
the areola, the dark circle around the nipple. It is rare, accounting
for only about 1% of all cases of breast cancer. The skin of the nipple
and areola often appears crusted, scaly, and red, with areas of
bleeding or oozing. The woman may notice burning or itching.
Paget disease is almost always associated with either ductal
carcinoma in situ (DCIS) or, more often, with infiltrating ductal
carcinoma. If no lump can be felt in the breast tissue and the biopsy
shows DCIS but no invasive cancer, the prognosis is excellent.
Tubular
carcinoma: Tubular carcinomas are another special type
of invasive ductal breast carcinoma. It was named tubular because of
the way the cells look under the microscope. Tubular carcinomas account
for about 2% of all breast cancers and tend to have a better prognosis
than infiltrating ductal or lobular carcinomas.
Papillary
carcinoma: The cells of these cancers tend to be
arranged in small, finger-like projections when viewed under the
microscope. These cancers are most often considered to be a subtype of
ductal carcinoma in situ (DCIS), and are treated as such. In rare cases
they are invasive, in which case they are treated like invasive ductal
carcinoma, although the outlook is likely to be better. These cancers
make up no more than 1% or 2% of all breast cancers, and they tend to
be diagnosed in older women.
Adenoid cystic
carcinoma (adenocystic carcinoma): These
cancers are so named because they have both glandular (adenoid) and
cylinder-like (cystic) features when viewed under the microscope. They
make up less than 1% of breast cancers. They rarely spread to the lymph
nodes or distant areas, and they tend to have a very good prognosis.
Phyllodes tumor:
This very rare breast tumor develops in the
stroma (connective tissue) of the breast, in contrast to carcinomas,
which develop in the ducts or lobules. Other names for these tumors
include phylloides
tumor and cystosarcoma
phyllodes. These tumors are
usually benign but on rare occasions may be malignant.
Benign phyllodes tumors are treated by removing the mass along
with a margin of normal breast tissue. A malignant phyllodes tumor is
treated by removing it along with a wider margin of normal tissue, or
by mastectomy. While surgery is often all that is needed, these cancers
may not respond as well to the other treatments used for invasive
ductal or lobular breast cancer.
Angiosarcoma:
This is a form of cancer that starts from cells
that line blood vessels. It rarely occurs in the breasts. When it does,
it is usually seen as a complication of radiation to the breast. It
tends to develop about 5 to 10 years after radiation treatment.
However, this is an extremely rare complication of breast radiation
therapy. Angiosarcoma can also occur in the arm of women who develop
lymphedema as a result of lymph node surgery or radiation therapy to
treat breast cancer. (For information on lymphedema, see the section,
"How
Is Breast Cancer Treated?") These cancers tend to grow and
spread
quickly. Treatment is generally the same as for other sarcomas (see the
American Cancer
Society document Soft
Tissue Sarcomas).
Revised: 09/13/2007
|